Latest Breaking News On - Lodo therapeutics - Page 1 : vimarsana.com

CARLSBAD, Calif., April 01, 2024 Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing allogeneic cell therapies for unmet medical needs, today announced the appointment of veteran industry executive Charlotte Hubbert, Ph.D., as Vice President of Corporate Development. Dr. Hubbert has an extensive background in cell therapy research and venture investment across a broad range of therapeutic modalities and development stages, and has a

University of washingtonUnited statesBrianm culleyCharlotte hubbertCorporate developmentUniversity of washington innovation roundtableAccelerator corporationExchange commissionHead of gates foundation venture capitalMelinda gates foundation strategic investment fundEterna therapeutics incDuke universityRoche groupVp corporate developmentFred hutch cancer institute evergreen fundInstitute for stem cells